What is the Projected CAGR value of the Melanoma Therapeutics Market?
Melanoma Therapeutics Market is expected to grow at a CAGR of 11.43% during the forecast period 2024-2031.
Who are the key players in the Melanoma Therapeutics Market?
Major players are Bristol-Myers Squibb Co., Merck, and Co., Inc., F. Hoffmann-La Roche, Ltd., AB Science S.A., Amgen, Inc., Celgene Corp., Daiichi Sankyo Co., Eisai Co., Ltd., GlaxoSmithKline, plc., and Pfizer, Inc.